Relationship Between Prenatal Maternal Distress and the Quality of General Movements at 3 Months
1 other identifier
observational
120
1 country
1
Brief Summary
Depression and anxiety symptoms are common during pregnancy which may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. There is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. The neurological footprints of these structural changes on the young brain may be caught early in life by a video assessment of General Movements (GMs) quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedStudy Start
First participant enrolled
February 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2023
CompletedDecember 8, 2023
December 1, 2023
8 months
January 12, 2023
December 7, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Relationship Between Prenatal Maternal Anxiety and the Quality of General Movements
Univariate statistical analyses will be performed to calculate differences in mothers' STAI-T scores between children with normal and abnormal GMs.
3-5 months
Relationship Between Prenatal Maternal Depression and the Quality of General Movements
Univariate statistical analyses will be performed to calculate differences in mothers' BDI scores between children with normal and abnormal GMs.
3-5 months
Secondary Outcomes (1)
Multivariate analyses will be carried out with control variables
3-5 months
Study Arms (2)
Mothers
Mothers aged 18 to 40 years, who have singleton pregnancy.
Infants
Infants were born at 36-42 weeks of gestation without complication.
Interventions
The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.
The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).
BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression
Eligibility Criteria
Mothers aged 18 to 40 years, who have singleton pregnancy. Infants were born at 36-42 weeks of gestation without complication.
You may qualify if:
- Mothers aged 18 to 40 years,
- Singleton pregnancy
- No smoking during prengnancy
- No illicit drug or alcohol use during pregnancy,
- No major health conditions requiring invasive treatments (e.g., dialysis, blood transfusions, chemotherapy),
- No diagnosis of psychotic illnesses (eg, schizophrenia,bipolar or borderline personality disorder), and
- No major autoimmune diseases
- No pregnancy-related complications: (including prenatal infection, pregnancy-included hypertension, gestational diabetes, oligohydramnios, polyhydramnios, preterm labor, vaginal bleeding, placenta previa, or anemia).
- infants were born at 36-42 wk of gestation
- uncomplicated singleton birth,
- no pre-existing neurologic conditions or major head trauma, neonatal intensive care unit stay limited to observation only (ie, no interventions), and
- infant discharged from the hospital with the mother.
You may not qualify if:
- post partum depression and/or anxiety
- delivery complication
- infant birth before 36 weeks gestation
- infant weight lower 2500gr at birth
- Apgar score 0f \<7 at 5 minutes
- Major neonatal complications
- Identified neurologic, genetic or congenital syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karaman Training and Research Hospital
Karaman, 70200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aynur Basaran, MD,Prof
Karaman Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Prof
Study Record Dates
First Submitted
January 12, 2023
First Posted
January 23, 2023
Study Start
February 17, 2023
Primary Completion
October 11, 2023
Study Completion
October 11, 2023
Last Updated
December 8, 2023
Record last verified: 2023-12